AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 86 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $47,000 | +30.6% | 80,201 | +12.6% | 0.00% | – |
Q3 2019 | $36,000 | +50.0% | 71,201 | +11.8% | 0.00% | – |
Q2 2019 | $24,000 | -33.3% | 63,701 | 0.0% | 0.00% | – |
Q1 2019 | $36,000 | +44.0% | 63,701 | 0.0% | 0.00% | – |
Q4 2018 | $25,000 | -3.8% | 63,701 | +28.2% | 0.00% | – |
Q3 2018 | $26,000 | -71.1% | 49,701 | +22.1% | 0.00% | -100.0% |
Q2 2018 | $90,000 | -41.2% | 40,701 | -9.4% | 0.00% | -50.0% |
Q1 2018 | $153,000 | -16.4% | 44,901 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $183,000 | +510.0% | 44,901 | -9.7% | 0.00% | – |
Q3 2017 | $30,000 | +57.9% | 49,701 | +39.2% | 0.00% | – |
Q2 2017 | $19,000 | -9.5% | 35,700 | +38.9% | 0.00% | – |
Q1 2017 | $21,000 | -8.7% | 25,700 | 0.0% | 0.00% | -100.0% |
Q4 2016 | $23,000 | +21.1% | 25,700 | 0.0% | 0.00% | – |
Q3 2016 | $19,000 | -42.4% | 25,700 | 0.0% | 0.00% | -100.0% |
Q2 2016 | $33,000 | – | 25,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
NTB Financial Corp | 146,100 | $83,000 | 0.06% |
Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |